Price target upside
Oramed Pharmaceuticals Inc. Price Target Upside or Downside
ORMP price target upside based on the current price and analyst average.
Direct answer
Oramed Pharmaceuticals Inc.'s analyst target implies +41.7%.
The average target is $6.25 compared with a recorded current price of $4.41.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 14, 2026.
Get free Oramed Pharmaceuticals Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.41
- Average price target
- $6.25
- High price target
- $6.25
- Low price target
- $6.25
- Target upside
- +41.7%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026